crta
Hrvatska znanstvena Sekcija img
bibliografija
3 gif
 Naslovna
 O projektu
 FAQ
 Kontakt
4 gif
Pregledavanje radova
Jednostavno pretraživanje
Napredno pretraživanje
Skupni podaci
Upis novih radova
Upute
Ispravci prijavljenih radova
Ostale bibliografije
Slični projekti
 Bibliografske baze podataka

Pregled bibliografske jedinice broj: 821737

Časopis

Autori: Tesar V; Troyanov S; Bellur S; Verhave JC; Cook HT; Feehally J; Roberts IS; Cattran D; Coppo R; VALIGA study of the ERA-EDTA Immunonephrology Working Group
Naslov: Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study
( Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study )
Izvornik: Journal of the American Society of Nephrology (1046-6673) 26 (2015), 9; 2248-2258
Vrsta rada: članak
Ključne riječi: IgA nephropathy ; immunosuppression ; pathology ; progression of chronic renal failure ; proteinuria ; risk factors
( IgA nephropathy ; immunosuppression ; pathology ; progression of chronic renal failure ; proteinuria ; risk factors )
Sažetak:
Current guidelines suggest treatment with corticosteroids (CS) in IgA nephropathy (IgAN) when proteinuria is persistently ≥1 g/d despite 3-6 months of supportive care and when eGFR is >50 ml/min per 1.73 m(2). Whether the benefits of this treatment extend to patients with an eGFR≤50 ml/min per 1.73 m(2), other levels of proteinuria, or different renal pathologic lesions remains unknown. We retrospectively studied 1147 patients with IgAN from the European Validation Study of the Oxford Classification of IgAN (VALIGA) cohort classified according to the Oxford-MEST classification and medication used, with details of duration but not dosing. Overall, 46% of patients received immunosuppression, of which 98% received CS. Treated individuals presented with greater clinical and pathologic risk factors of progression. They also received more antihypertensive medication, and a greater proportion received renin angiotensin system blockade (RASB) compared with individuals without immunosuppressive therapy. Immunosuppression was associated with a significant reduction in proteinuria, a slower rate of renal function decline, and greater renal survival. Using a propensity score, we matched 184 subjects who received CS and RASB to 184 patients with a similar risk profile of progression who received only RASB. Within this group, CS reduced proteinuria and the rate of renal function decline and increased renal survival. These benefits extended to those with an eGFR≤50 ml/min per 1.73 m(2), and the benefits increased proportionally with the level of proteinuria. Thus, CS reduced the risk of progression regardless of initial eGFR and in direct proportion to the extent of proteinuria in this cohort.
Projekt / tema: 198-0000000-3355
Izvorni jezik: eng
Rad je indeksiran u
bazama podataka:
Current Contents Connect (CCC)
MEDLINE
Scopus
SCI-EXP, SSCI i/ili A&HCI
Science Citation Index Expanded (SCI-EXP) (sastavni dio Web of Science Core Collectiona)
Kategorija: Znanstveni
Znanstvena područja:
Kliničke medicinske znanosti
URL Internet adrese: http://jasn.asnjournals.org/content/26/9/2248.long
URL cjelovitog teksta:
Google Scholar: Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study
Upisao u CROSBI: Danica Ljubanović (danica.ljubanovic@zg.t-com.hr), 15. Lip. 2016. u 20:11 sati
Napomene:
Group Author(s): VALIGA Study ERA-EDTA (hrvatski suradnici: Krešimir Galešić i Danica Galešić- Ljubanović)



  Verzija za printanje   za tiskati


upomoc
foot_4